News
New Parkinson's Gene is Linked to Immune System - 08/27/2010
A hunt throughout the human genome for variants associated with common late-onset Parkinson's disease has revealed a new genetic link that implicates the immune system and offers new targets for drug development.
NeuroDerm Ltd Announces Positive Results of a
NESS ZIONA, Israel, November 9, 2011 /PRNewswire/ --NeuroDerm, Ltd. announced today the results of a Phase I/II safety and pharmacokinetic trial of
Parkinson’s drug market set to expand with over 300 late-stage trials currently in progress | PRLog
Parkinson’s drug market set to expand with over 300 late-stage trials currently in progress. Piribo, the online destination for Pharma intelligence, has added a new report. - PR11713507
Insider Buying On Impax After Parkinson's Drug Study Results - Seeking Alpha
< strong > By < a href='http://biomedreports.com/' > M.E. Garza < /a > : < /strong > < p > Early last week Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. ( < a href='http://seekingalpha.com/symbol/ipxl' title='Impax Laboratories, Inc.' > IPXL < /a > ), and
'Brain bank' boosts Parkinson's research - Scotsman.com News
'Brain bank' boosts Parkinson's research - A "BRAIN bank" of artificially grown nerve cells is being developed by British researchers studying Parkinson's disease.
Abbott Reports Interim Results from Phase III Open-Label Study of Investigational Treatment for
Abbott Reports Interim Results from Phase III Open-Label Study of Investigational Treatment for Advanced Parkinson's Disease
Medical News: Welders at Risk of Neuronal Damage - in Neurology, Parkinson's Disease from MedPage
Welders, who have occupational exposure to manganese fumes, may be at risk for developing parkinsonism-like neuronal damage, imaging studies suggested.
US study links pesticides to Parkinson's disease - Yahoo! News UK
US researchers said Friday they have found that people who used two specific varieties of pesticide were 2.5 times as likely to develop Parkinson's disease.
Acadia | Pharma Asia
December 14, 2010 Home About Us Current Issue Archives Events RSS Feeds More Advertising Information Editorial Information Technical Channels Drug Discovery Drug Development Drug Manufacturing Drug Delivery Clinical Trials
Understanding the neurocognitive aspects of Parkinson's disease : The Lancet Neurology
Understanding the neurocognitive aspects of Parkinson's disease. By - Matthias Löhle
Refine by Content Type:
Refine by Source:
- www.thelancet.com (318)
- download.thelancet.com (82)
- www.webmd.com (28)
- www.medpagetoday.com (23)
- news.scotsman.com (10)
- www.aerzteblatt.de (10)
- www.prlog.org (9)
- www.biospace.com (7)
- www.medport.de (5)
- www.em-consulte.com (4)
- www.frost.com (3)
- www.genengnews.com (2)
